ANSWER THE FOLLOWING QUESTIONS BY CIRCLING THE CORRECT ANSWERS
- Do Perioperative Beta-Blockers Reduce Mortality? Elliott, William T. // Hospital Medicine Alert;Jun2013 Pharmacology Watch, p1
The article reports a study which found that in patients with 2 or more cardiac risk factors undergoing noncardiac, nonvascular surgery, perioperative beta-blocker exposure was associated with lower rates of 30-day all-cause mortality supporting the use of drugs in these patients.
- Do Perioperative Beta-Blockers Reduce Mortality? Elliott, William T. // OB/GYN Clinical Alert;Jun2013 Pharmacology Watch, p1
The article presents information on a study related to the use of preoperative beta-blockers. It informs that the study conducted by the U.S. Department of Veterans Affairs (VA) suggests that the drugs may be of benefit in selected patients. It further informs about the actions taken by the U.S....
- Perioperative beta-blockers. Elliott, William T. // Clinical Oncology Alert;Jun2013 Pharmacology Watch, p1
The article discusses a study from the U.S. Department of Veterans Affairs (VA), which found that the use of drugs like perioperative beta-blockers may be of benefit in the case of some patients. The effect of perioperative beta-blockers were found to be greater in patients with higher cardiac...
- Most needy miss out on Î’-blockers. // Pulse;10/4/2004, Vol. 64 Issue 39, p7
Reports that patients who would benefit most from beta blockers are least often receiving them in Great Britain. Conditions prevented by beta blockers.
- Antiarrhythmic Action of Î²-Blockers: Potential Mechanisms. Dorian, Paul // Journal of Cardiovascular Pharmacology & Therapeutics;Jun2005 Supplement, Vol. 10 Issue 2S, pS15
The article reports that multiple direct and indirect mechanisms of adrenergic action on the heart may benefit from the known antiarrhythmic actions of Î²-blocker therapy and other interventions that decrease sympathetic tone. The blockers in the heart are responsible for the primary direct...
- Beta-blockers: Beyond cardiology. Daroff, Robert B.; Frishman, William H.; Lederman, Richard J.; Stewart, William C.; Millard, William B. // Patient Care;6/15/1993, Vol. 27 Issue 11, p47
Discusses the non-cardiologic uses of beta-blockers. List of beta-blockers approved for glaucoma; Complications of topical beta-blockers in the central nervous system; Factors considered in the administration of beta-blockers for migraine.
- Does Î²-blocker prophylaxis improve survival after major noncardiac surgery? Terblanche, Marius; Adhikari, Neill K. J.; Scales, Damon C. // CMAJ: Canadian Medical Association Journal;10/11/2005, Vol. 173 Issue 8, p874
Presents a study on the relation of Î²-blockade therapy and the risk of death after major noncardiac surgery. Number of study participants; Limitations of the study; Implications of the study.
- Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or ... Waagstein, F.; Str�mblad, O.; Andersson, B.; B�hm, M.; Darius, M.; Delius, W.; Goss, F.; Osterziel, K.J.; Sigmund, M.; Trenkwalder, S.-P.; Wahlqvist, I. // European Journal of Heart Failure;Oct2003, Vol. 5 Issue 5, p679
Background: the effects of long-term administration of ï¿½-blockers on left ventricular (LV) function during exercise in patients with ischemic heart disease (IHD) and idiopathic dilated cardiomyopathy (DCM) are controversial. Patients and methods: patients with stable congestive heart...
- Beta-Blockers to Reduce Mortality in Patients with Systolic Dysfunction. Lee, Susanne; Spencer, Anne // Journal of Family Practice;Jun2001, Vol. 50 Issue 6, p499
OBJECTIVE: We reviewed published clinical trials and performed a meta-analysis to assess if therapy with adrenergic b-antagonists (b-blockers) reduces the risk of mortality in patients with systolic dysfunction. STUDY DESIGN: A systematic review was performed with meta-analysis where...